A retroviral vector that allows efficient co-expression of two genes and the versatility of alternate selection markers

Human Gene Therapy

Volumn 8, Issue 8, 1997, Pages 979-983

  Saleh, Mary ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CISTRON; EXPRESSION VECTOR; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; MAMMAL CELL; MARKER GENE; MOLECULAR CLONING; NONHUMAN; RETROVIRUS;

EID: 0030999649     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.8-979     Document Type: Article

References (27)

1. ADAM, M.A., RAMESH, N., MILLER, A.D., and OSBORNE, W.R. (1991). Internal initiation in retroviral vectors carrying picornavirus 5′ nontranslated regions. J. Virol. 65, 4985-4990.
2. ANDERSON, F.W. (1994). Gene therapy for cancer. Hum. Gene Ther. 5, 1-2.
3. ARAN, J.M., GOTTESMAN, M.M., and PASTAN, I. (1994). Drug-selected co-expression of human glucocerebrosidase and P-glycoprotein using a bicistronic vector. Proc. Natl. Acad. Sci. USA 91, 3176-3180.
4. CEPKO, C.L., ROBERTS, B.E., and MULLIGAN, R.C. (1984). Construction and application of a highly transmissible murine retrovirus shuttle vector. Cell 37, 1053-1062.
5. GHATTAS, I.R., SANES, J.R., and MAJORS, J.E. (1991). The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell. Biol. 11, 5848-5859.
6. GRAHAM, F.L., and VAN DER EB, A.J. (1973). Transformation of rat cells by DNA of human adenovirus 5. Virology 54, 536-539.
7. HASAHARA, N., DOZY, AM., and KAN, Y.W. (1994). Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 266, 1373-1376.
8. JANG, S.K., and WIMMER, E. (1990). Cap-independent translation of encephalomyocarditis virus RNA: Structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes & Dev. 4, 1560-1572.
9. JANG, S.K., KRAUSSLICH, H.-G., NICKLIN, M.J.H., DUKE, G.M., PALMENBERG, A.C., and WIMMER, E. (1988). A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62, 2636-2643.
10. JANG, S.K., DAVIES, M.V., KAUFMAN, R.J., and WIMMER, E. (1989). Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J. Virol. 63, 1651-1660.
11. KOO, H., BROWN, A.M.C., KAUFMAN, R.J., PROROCK, C.M., RON, Y., and DOUGHERTY, J.P. (1992). A spleen necrosis virus-based retroviral vector which expresses two genes from a dicistronic mRNA. Virology 186, 669-675.
12. LYERLY, H.K., and DIMAIO, J.M. (1993). Gene delivery systems in surgery. Arch. Surg. 128, 1197-1206.
13. MARKOWITZ, D., HESDORFFER, C., WARD, M., GOFF, S., and BANK, A. (1990). Retroviral gene transfer using safe and efficient packaging cell lines. Ann. N.Y. Acad. Sci. 612, 407-414.
14. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-990.
15. MOSLEY, B., BECKMANN, P., MARCH, C.J., IDZERDA, I.S., GIMPEL, S., D., VANDENBOS, T., FRIEND, D., ALPERT, A., ANDERSON, D., JACKSON, J., WIGNALL, J., M., SMITH, C., GALLIS, B., SIMS, B.E., URDAL, D., WIDMER, M.B., COSMAN, D., and PARK, L.S. (1996). The murine inerleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms. Cell 59, 335-348.
16. MOUNTFORD, P., ZEVNIK, B., DUWELL, A., NICHOLS, J., LI, M., DANI, C., ROBERTSON, M., CHAMBERS, I., and SMITH, A. (1994). Dicistronic targeting constructs: Reporters and modifiers of mammalian gene expression. Proc. Natl. Acad. Sci. USA 91, 4303-4307.
17. MAPK. Blood 86, 3698-3704.
18. OLDFIELD, E.H., RAM, Z., BLAESE, R.M., and DEVROOM, H.L. (1993). Gene therapy for the treatment of brain tumors using intratumoral transduction with the thymidine kinase and intravenous gancyclovir. Hum. Gene Ther. 4, 39-69.
19. RAM, Z., CULVER, K.W., WALBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993a). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
20. RAM, Z., CULVER, K.W., WALBRIDGE, S., FRANK, J.A., BLAESE, R.M., and OLDFIELD, E.H. (1993b). Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J. Neurosurg. 79, 400-407.
21. RAM, Z., WALBRIDGE, S., SHAWKER, T., CULVER, K.W., BLAESE, M., and OLDFIELD, E.H. (1994). The effect of thymidine kinase transduction and gancylovir therapy on tumour vasculature and growth of PL gliomas in rats. J. Neurosurg. 81, 256-260.
22. ROBERTSON, E., BRADLEY, A., KUEHN, M., and EVANS, M. (1986). Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323, 445-448.
23. ROSENBERG, S.A., ANDERSON, W.F., ASHER, A.L., BLAESE, M.R., ETTINGHAUSSEN, S.E., HWU, P., KASID, A., MULE, J.J., PARKINSON, D.R., SCHWATRZENTRUBER, D.J., TOPALIAN, S.L., WEBER, J.S., ANNELLI, J.R., YANG, J.C., and LINEHAN, W.M. (1992a). Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for tumor necrosis factor. Hum. Gene Ther 3, 57-73.
24. ROSENBERG, S.A., ANDERSON, W.F., BLAESE, M.R., ETTINGHAUSSEN, S.E., HWU, P., KARP, S.E., KASID, A., MULE, J.J., PARKINSON, D.R., SALO, J.C., SCHWARTZENTRUBER, D.J., TOPALIAN, S.L., WEBER, J.S., YANNELLI, J.R., YANG, J.C., and LINEHAN, W.M. (1992b). Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for interleukin-2. Hum. Gene Ther 3, 75-90.
25. SALEH, M., STACKER, S.A., and WILKS, A.F. (1996). Inhibition of growth of C6 glioma cells in vivo by expression of antisense Vascular Endothelial Growth Factor (VEGF) sequence. Cancer Res. 56, 393-401.
26. TAHARA, H., ZITVOGEL, L., STORKUS, W.J., ZEH III, H.J., MCKINNEY, T.G., SCHREIBER, R.D., GUBLER, U., ROBBINS, P.D., and LOTZE, M.T. (1995). Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154, 6466-6474.
27. TAKIMAYA, Y., SHORT, M.P., EZZEDINE, Z.D., MOOLTEN, F.L., BREAKEFIELD, X.O., and MARTUZZA, R.L. (1992). Gene therapy of malignant brain tumors: A rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumour cells. J. Neurosci. Res. 33, 493-503.